Canada Markets closed

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0530-0.0019 (-3.46%)
At close: 03:59PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -1.08
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.0400
52 Week Low 30.0410
50-Day Moving Average 30.0694
200-Day Moving Average 30.5694

Share Statistics

Avg Vol (3 month) 31.84M
Avg Vol (10 day) 33.3M
Shares Outstanding 5163.14M
Implied Shares Outstanding 6N/A
Float 885.14M
% Held by Insiders 10.35%
% Held by Institutions 18.38%
Shares Short (Jul 28, 2022) 48.68M
Short Ratio (Jul 28, 2022) 40.19
Short % of Float (Jul 28, 2022) 411.01%
Short % of Shares Outstanding (Jul 28, 2022) 410.98%
Shares Short (prior month Jun 29, 2022) 417.82M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 17, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jan 17, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-861.66%

Management Effectiveness

Return on Assets (ttm)-103.36%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)15.57M
Revenue Per Share (ttm)1.05
Quarterly Revenue Growth (yoy)224.90%
Gross Profit (ttm)4.19M
EBITDA -133.07M
Net Income Avi to Common (ttm)-282.7M
Diluted EPS (ttm)-2.1190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.89M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)125.74M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.16
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-106.21M
Levered Free Cash Flow (ttm)68.23M